Table 2.
Diagnosis | N%(≤49) | N%(50-69) | N%(≥70) | N%(all) |
---|---|---|---|---|
malignant | ||||
HCC | 57.95% (51/88) | 55.05% (60/109) | 25.33% (19/75) | 47.79% (130/272) |
cholangiocarcinoma | 4.55% (4/88) | 6.42% (7/109) | 13.33% (10/75) | 7.72% (21/272) |
metastases | 1.14% (1/88) | 8.26% (9/109) | 38.67% (29/75) | 13.34% (39/272) |
other malignant | 0 | 0.09% (1/109) | 0 | 0.37% (1/272) |
benign | 36.36% (32/88) | 29.36% (32/109) | 22.67% (17/75) | 29.78% (81/272) |
n(total) | 88 | 109 | 75 | 272 |